Last Updated: 06-Sep-2026

Epiluminescence Microscopy Market Size, Share, Growth, and Industry Analysis, By Type (Traditional Dermatoscope, Digital Dermatoscope), By Application (Hospital, Clinic, Other), Regional Insights and Forecast to 2035

$485.06M
2025 Market Size
Base Year Value
$1340.69M
By 2035
Forecast Value
12.1%
CAGR
2026 – 2035
9 Yrs
Coverage
Forecast Period

Epiluminescence Microscopy Market Overview

Global Epiluminescence Microscopy market size is projected at USD 485.06 million in 2026 and is expected to hit USD 1340.69 million by 2035 with a CAGR of 12.1%.

The Epiluminescence Microscopy market is entering a period of sustained expansion as dermatology practices increasingly prioritize earlier lesion assessment, standardized image documentation, and non-invasive examination methods. Demand is being supported by improvements in optical illumination, polarized imaging, digital image capture, and software-assisted lesion comparison. Digital Dermatoscope systems are gaining importance as clinics seek faster documentation and easier longitudinal monitoring, while Traditional Dermatoscope equipment continues to serve settings where portability, straightforward operation, and lower system complexity remain important. The market is also benefiting from broader dermatological screening activity, with healthcare providers increasingly incorporating dermatoscopic examination into routine assessments. Across the forecast period, manufacturers are concentrating on improving optical clarity, reducing device weight, enhancing image consistency, and integrating connectivity features. Product development is increasingly focused on achieving approximately 15% improvements in image acquisition efficiency and reducing examination workflow time by around 12%, supporting wider use across professional dermatology environments.

The U.S. Epiluminescence Microscopy market is supported by expanding dermatology services, greater emphasis on early identification of suspicious skin lesions, and increasing use of digitally documented examinations. Hospitals and clinics are adopting imaging systems that can preserve lesion images for follow-up comparisons, with digital workflows increasingly reducing manual documentation requirements by approximately 20%. Digital Dermatoscope solutions are particularly relevant to specialist practices because they can support image archiving, patient monitoring, and standardized examination procedures. Demand is also influenced by the growing role of outpatient dermatology, where compact equipment and rapid examination capabilities can improve daily patient throughput. Product manufacturers are therefore emphasizing ergonomic designs, high-resolution imaging, polarized illumination, and software compatibility. The U.S. market is expected to maintain a strong position as healthcare providers increasingly seek examination tools that combine visual assessment with repeatable documentation, while replacement demand is strengthened by device utilization, technology upgrades, and the need to maintain consistent imaging performance across established clinical installations.

Key Findings

  • Key Market Driver: Increasing demand for non-invasive skin lesion assessment and digital documentation is accelerating adoption, with examination workflow efficiency improvements of approximately 10% supporting wider clinical utilization.
  • Major Market Restraint: Equipment investment, operator training, and workflow adaptation can limit adoption, with implementation and staff familiarization periods potentially extending from 6 to 12 months in some facilities.
  • Emerging Trends: Digital imaging, polarized illumination, connected documentation, and image-assisted workflows are shaping product innovation, with Digital Dermatoscope systems accounting for approximately 57% of product-type demand.
  • Regional Leadership: North America is expected to lead the global market with approximately 31% share, supported by established dermatology infrastructure, specialist services, digital healthcare adoption, and strong demand for advanced imaging equipment.
  • Competitive Landscape: Competition is increasingly centered on optical precision, digital connectivity, ergonomic design, and workflow integration, with the top two companies together estimated to hold approximately 25% market share.
  • Market Segmentation: Digital Dermatoscope leads product demand with approximately 57% share, while Clinic applications dominate at about 46%, reflecting strong demand for digital documentation, repeat examinations, and longitudinal lesion monitoring.
  • Recent Development: Product development is increasingly focused on compact connected imaging and improved optical consistency, with selected systems targeting approximately 12% improvements in illumination and image-quality consistency.
The latest development direction in Epiluminescence Microscopy is increasingly defined by the convergence of optical precision and digital workflow management. Manufacturers are improving illumination uniformity, polarization control, lens performance, image sensors, and ergonomic handling to provide more repeatable examination conditions. Modern devices are increasingly designed to minimize reflections and improve visualization of subsurface skin structures, helping clinicians distinguish subtle pigmentation and vascular patterns more consistently. Digital Dermatoscope platforms are particularly aligned with this shift, accounting for approximately 57% of product-type demand, as image capture can be integrated into examination documentation and follow-up procedures. Product engineering programs are targeting approximately 12% improvements in illumination consistency and around 10% gains in image-capture responsiveness. These improvements are also being paired with lighter housings, simplified controls, and rechargeable power systems, allowing equipment to move more easily between examination rooms. The combination of optical performance and workflow efficiency is making epiluminescence microscopy increasingly relevant to dermatology practices seeking standardized examination processes without significantly increasing consultation time.

Market Dynamics

Driver

"Growing demand for earlier and more consistent skin lesion assessment."

The primary growth driver for the Epiluminescence Microscopy market is the expanding use of non-invasive examination techniques for evaluating pigmented lesions and other visible skin abnormalities. Dermatology providers increasingly value imaging methods that can reveal structural patterns not readily visible through conventional inspection, supporting more systematic clinical assessment. The growing emphasis on early identification is encouraging hospitals and clinics to incorporate dermatoscopic examination into routine workflows, particularly where patient volumes and follow-up requirements are increasing. Examination efficiency is becoming a major purchasing consideration, with modern equipment targeting workflow improvements of approximately 10% compared with less integrated examination procedures.

Digital documentation is further strengthening demand because clinicians can retain images for subsequent comparison and patient monitoring. Repeat examinations can benefit from standardized imaging conditions, enabling practitioners to identify changes in lesion appearance over time. Hospitals and specialist clinics are therefore evaluating systems not only for optical performance but also for documentation capability and ease of integration. Digital workflows can reduce manual image-recording activities by approximately 20%, creating a measurable operational benefit for practices managing high examination volumes. This combination of diagnostic visualization, documentation, and workflow efficiency is expected to remain a central demand driver through the forecast period.

Restraint

"Equipment cost and operator expertise can slow broader adoption."

One of the principal restraints affecting Epiluminescence Microscopy adoption is the need to balance equipment investment with clinical utilization. Advanced systems incorporating digital imaging, high-quality optics, specialized illumination, and software capabilities can require greater initial expenditure than basic examination devices. Smaller clinics with limited equipment budgets may therefore prioritize essential functionality over advanced digital features. In addition, purchasing decisions can involve evaluation periods of approximately 6 months when providers compare optical quality, software usability, service support, and compatibility with existing clinical workflows.

Operator expertise represents another limitation because image interpretation depends substantially on clinical experience and standardized examination technique. Even technically advanced equipment cannot fully eliminate differences in interpretation between practitioners. Training programs, workflow adjustments, and equipment familiarization can require several weeks before users achieve consistent operating proficiency. In some facilities, implementation and staff adaptation may extend toward 6 to 12 months when new digital documentation processes are introduced alongside the imaging device. These factors can moderate replacement cycles and delay adoption in lower-volume practices, particularly where the immediate operational return is difficult to quantify.

Opportunity

"Digital connectivity and longitudinal imaging create significant expansion potential."

The transition toward digitally documented dermatology creates substantial opportunity for Epiluminescence Microscopy manufacturers. Digital Dermatoscope systems can support image archiving, lesion comparison, clinical documentation, and patient follow-up, creating additional value beyond the immediate examination. As dermatology practices expand their use of electronic workflows, connected imaging devices can become part of broader digital examination environments. Manufacturers capable of delivering reliable image transfer, secure storage, and intuitive interfaces can address practices seeking to reduce administrative workload by approximately 15% while improving access to historical images.

Emerging demand from outpatient clinics and specialized dermatology centers also provides room for compact equipment designed for flexible deployment. Smaller systems can be moved between consultation rooms and specialized examination areas without requiring extensive installation infrastructure. Product developers are increasingly targeting footprint reductions of approximately 10% while preserving optical performance and image consistency. Another opportunity lies in integrating imaging with longitudinal monitoring, where standardized photographs can support repeated examinations over periods of several months or years. Such capabilities can strengthen equipment utilization and encourage clinics to upgrade from basic Traditional Dermatoscope systems toward more digitally enabled platforms.

Challenge

"Maintaining image consistency across users and clinical environments remains challenging."

A major technical challenge is achieving consistent imaging performance across different operators, examination locations, skin conditions, and lighting environments. Small variations in device angle, contact pressure, illumination, or image capture distance can affect the appearance of a lesion and complicate longitudinal comparison. Manufacturers are therefore investing in optical calibration, illumination control, ergonomic design, and standardized image acquisition. Selected product-development programs are targeting approximately 5% to 10% improvements in image consistency through better illumination and positioning mechanisms.

Another challenge involves balancing advanced functionality with ease of use. Adding wireless connectivity, image-management software, automated settings, and higher-resolution sensors can increase system complexity if interfaces are not designed around clinical workflows. Clinics generally require devices that can be operated quickly during patient consultations, particularly when daily examination volumes exceed several dozen cases. Manufacturers must therefore maintain a practical balance between technological sophistication and usability. Product qualification, software validation, cybersecurity requirements, and compatibility testing can also extend development timelines by approximately 6 to 12 months, making efficient product engineering and reliable post-installation support increasingly important competitive factors.

Epiluminescence Microscopy Market Segmentation

Global Epiluminescence Microscopy Market Size, 2035

By Types

Traditional Dermatoscope: Traditional Dermatoscope systems remain an important part of the Epiluminescence Microscopy market because they provide direct optical visualization with relatively simple operating procedures. This segment is estimated to account for approximately 43% of total type demand in 2026. Their continued use is supported by portability, straightforward handling, lower system complexity, and suitability for routine examinations in clinics and hospital dermatology departments. Providers that do not require extensive digital archiving may continue to favor conventional optical configurations, particularly where examination speed and equipment mobility are prioritized.

Demand for Traditional Dermatoscope products is also being sustained by replacement requirements and the need for dependable examination equipment across multiple clinical environments. Manufacturers are improving lens quality, illumination uniformity, polarization, grip ergonomics, and housing durability without significantly increasing operational complexity. Recent design improvements are targeting approximately 12% better illumination consistency and around 10% longer expected component durability in selected configurations. The segment is likely to remain relevant because many dermatology professionals value direct visual assessment and rapid examination without relying on complex software or connected infrastructure.

Digital Dermatoscope: Digital Dermatoscope systems represent the leading product segment, with an estimated market share of approximately 57%. Growth is being supported by increasing demand for image capture, digital storage, lesion comparison, and longitudinal patient monitoring. Digital platforms allow clinicians to retain examination records and compare images across multiple visits, making them particularly attractive to practices that manage recurring dermatology assessments. Improvements in sensor resolution, image processing, illumination, and connectivity are further increasing the usefulness of digital equipment in professional workflows.

The Digital Dermatoscope segment is also benefiting from the increasing digitization of clinical documentation. Advanced systems can reduce repetitive documentation tasks and improve access to historical images, with workflow efficiency gains of approximately 20% achievable in well-integrated examination environments. Manufacturers are concentrating on compact housings, wireless connectivity, improved battery operation, and intuitive software interfaces. Development programs are also evaluating image-assistance technologies capable of supporting standardized assessment while keeping clinical interpretation under professional control. As clinics seek more efficient examination and documentation processes, Digital Dermatoscope demand is expected to remain the principal source of product-level expansion.

By Applications

Hospital: Hospitals are estimated to account for approximately 34% of Epiluminescence Microscopy application demand, supported by multidisciplinary dermatology services, specialist consultation, and higher patient examination volumes. Hospital departments often require equipment that can support standardized imaging across different clinicians and examination rooms. Digital documentation is particularly valuable where patients undergo repeated evaluations, because archived images can facilitate comparison during follow-up appointments. Procurement decisions typically consider optical performance, durability, service availability, image management, and compatibility with existing clinical workflows.

Hospital demand is also being influenced by the expansion of specialized dermatology services and greater emphasis on non-invasive assessment. Equipment utilization can be distributed across several practitioners, increasing the importance of consistent image quality and ergonomic operation. Hospitals may use systems for both routine assessments and more specialized examinations, creating demand for flexible configurations. Manufacturers are therefore developing products capable of supporting repeated daily use, with selected designs targeting approximately 10% improvements in operational durability. Integration with digital records and structured image storage is expected to remain an important purchasing consideration as hospitals continue modernizing clinical documentation.

Clinic: Clinic applications represent the largest application segment, accounting for approximately 46% of market demand. Dermatology clinics frequently depend on rapid, repeatable examination procedures and increasingly require imaging systems that can support both immediate visualization and patient documentation. Digital Dermatoscope platforms are particularly relevant to this segment because they can capture and organize lesion images during consultations. The combination of portability, faster documentation, and longitudinal monitoring makes advanced microscopy equipment increasingly attractive to specialist practices and outpatient dermatology centers.

Clinic-based adoption is also supported by the need to maximize examination efficiency without adding unnecessary complexity to consultation workflows. Compact devices with integrated illumination and simplified controls can be deployed across multiple consultation rooms, while connected systems can facilitate image transfer and follow-up comparisons. Manufacturers are targeting approximately 10% reductions in examination workflow time through improved controls and digital documentation features. Clinics with higher patient throughput are expected to continue upgrading from basic optical equipment toward digitally enabled systems that offer better image management and repeat-examination capabilities.

Other: Other applications account for approximately 20% of market demand and include professional settings outside the principal hospital and clinic categories. This segment can include specialized dermatology services, academic environments, training facilities, and other professional examination settings where epiluminescence imaging is used for visualization, education, documentation, or clinical assessment. Demand is influenced by the portability and flexibility of available equipment, particularly where systems must be moved between examination or teaching areas.

Purchasers in this segment generally place importance on ease of operation, compact design, reliable illumination, and practical image capture. Equipment with simpler installation requirements can be advantageous where dedicated imaging infrastructure is limited. Digital systems are gradually increasing their presence because archived images can support teaching, case review, and longitudinal assessment. Selected compact designs are targeting approximately 10% reductions in physical footprint while maintaining optical performance, allowing these products to serve environments where space, mobility, and flexible deployment are important purchasing considerations.

Regional Outlook

Global Epiluminescence Microscopy Market Share, by Type 2035

North America

North America is expected to maintain the leading regional position in the Epiluminescence Microscopy market, representing approximately 31% of global demand. The region benefits from established dermatology infrastructure, specialist physician networks, relatively high adoption of digital clinical workflows, and strong demand for advanced diagnostic visualization. Hospitals and clinics are increasingly incorporating digital documentation into routine dermatology examinations, supporting demand for Digital Dermatoscope equipment with image storage and comparison capabilities.

Regional demand is also being influenced by replacement activity and continued improvements in outpatient dermatology services. Clinics are seeking compact devices that can support rapid consultations while maintaining high-quality imaging, while larger healthcare organizations are evaluating systems based on interoperability and documentation efficiency. Digital workflow adoption can reduce repetitive image-management tasks by approximately 20%, strengthening the operational case for upgraded equipment. Manufacturers serving North America are therefore emphasizing optical precision, connectivity, ergonomic design, and service support to address increasingly sophisticated purchasing requirements.

Europe

Europe is estimated to account for approximately 25% of the global Epiluminescence Microscopy market. Demand is supported by established dermatological care networks, increasing attention to early lesion assessment, and the growing adoption of standardized imaging procedures. Healthcare providers are increasingly interested in examination systems that can support documentation and follow-up without adding substantial consultation time. Digital Dermatoscope products are consequently gaining importance among specialist practices that require repeatable image capture and longitudinal monitoring.

European demand is also shaped by purchasing emphasis on product quality, usability, durability, and efficient resource utilization. Clinics and hospitals are evaluating systems capable of supporting multiple examinations per day while maintaining consistent optical output. Manufacturers are responding with improved illumination systems, compact housings, and simplified controls, with selected product programs targeting approximately 12% improvements in imaging consistency. Replacement opportunities are expected to remain significant as older optical systems are upgraded with digital functionality and improved image-management capabilities.

Asia-Pacific

Asia-Pacific is projected to represent approximately 28% of global Epiluminescence Microscopy demand and is expected to remain one of the fastest-expanding regional markets. Growth is supported by increasing healthcare infrastructure, expanding specialist services, rising dermatology awareness, and broader availability of advanced clinical equipment. Hospitals and clinics in major urban centers are increasingly adopting digital examination technologies, while improving healthcare access is creating additional opportunities outside established metropolitan markets.

The region also presents opportunities for manufacturers offering compact and cost-efficient equipment. Clinics with constrained examination space can benefit from lightweight systems that combine optical visualization with digital documentation. Product developers are increasingly targeting footprint reductions of approximately 10% while retaining stable image quality. Growing demand for patient monitoring and repeat examinations is expected to support Digital Dermatoscope adoption, while Traditional Dermatoscope systems will continue serving facilities where simple operation and lower technology complexity remain important considerations.

Middle East and Africa

The Middle East and Africa region is estimated to contribute approximately 7% of global market demand. Adoption is supported by the gradual development of specialized dermatology services, hospital modernization programs, and increasing availability of advanced diagnostic equipment in major healthcare centers. Larger hospitals and private medical facilities are important demand points because they often have greater capacity to invest in specialist imaging technologies and digital clinical infrastructure.

Market expansion remains influenced by equipment affordability, specialist availability, training requirements, and service accessibility. Manufacturers can address these factors by offering durable systems with simplified operating procedures and manageable maintenance requirements. Compact devices can also provide practical advantages in facilities where examination rooms have limited space. Selected product improvements targeting approximately 10% longer operating durability can strengthen the value proposition for facilities where replacement and maintenance logistics are more challenging. Over time, broader specialist coverage and improving digital healthcare infrastructure are expected to support incremental adoption.

Rest of World

Rest of World is estimated to represent approximately 9% of global Epiluminescence Microscopy demand. This market grouping includes healthcare environments where adoption is developing at different speeds according to dermatology infrastructure, medical technology investment, and specialist availability. Demand is increasingly concentrated in private healthcare facilities, specialist practices, and institutions seeking modern visualization tools for lesion assessment and documentation.

Growth opportunities in these markets are closely linked to product affordability, portability, and ease of implementation. Equipment that requires limited infrastructure can be particularly suitable for smaller specialist facilities, while digital systems offer advantages for documentation and remote access to stored images. Manufacturers are increasingly balancing advanced functionality with straightforward operation, targeting approximately 10% reductions in setup or workflow complexity for selected designs. As professional dermatology services expand, demand for both Traditional Dermatoscope and Digital Dermatoscope equipment is expected to increase across specialized healthcare environments.

List of Top Epiluminescence Microscopy Companies

  • Dermlite
  • Heine
  • Dino-Lite
  • Canfield Scientific
  • WelchAllyn
  • AMD Global
  • KaWe
  • FotoFinder
  • Caliber I.D.
  • Firefly Global
  • Metaoptima

Top 2 Companies with Highest Market Share

  • Dermlite: Dermlite is estimated to hold approximately 14% of the global Epiluminescence Microscopy market, supported by strong recognition in professional dermatoscopy and a broad emphasis on optical performance and ergonomic design. Its competitive position is reinforced by demand for portable equipment and continued development of imaging solutions designed for efficient clinical examination.
  • Heine: Heine is estimated to account for approximately 11% of global market demand, supported by its established position in professional diagnostic instruments and emphasis on optical quality. The combined estimated share of the two leading companies is approximately 25%, indicating a market with several established participants rather than a single dominant supplier.

Investment Analysis and Opportunities

Investment opportunities in the Epiluminescence Microscopy market are increasingly concentrated around digital imaging, optical engineering, compact device manufacturing, and clinical workflow integration. Capital allocation is likely to favor technologies capable of improving image consistency, reducing examination time, and simplifying digital documentation. Digital Dermatoscope products represent a particularly attractive investment area because their approximately 57% product share demonstrates strong demand for digitally enabled examination capabilities. Investors are also evaluating opportunities in image-management software, sensor technologies, illumination systems, and ergonomic hardware that can enhance product differentiation without creating excessive equipment complexity.

Regional expansion provides another investment pathway, particularly in Asia-Pacific and emerging healthcare markets where specialist dermatology infrastructure continues to develop. Investment in localized distribution, technical support, clinician training, and service networks can improve market access and encourage replacement activity. Manufacturers may also benefit from compact products designed for clinics with limited space, with footprint optimization of approximately 10% becoming increasingly relevant. Over the medium term, investment strategies are likely to emphasize scalable digital platforms, recurring equipment upgrades, stronger aftermarket services, and partnerships that accelerate adoption among specialist healthcare providers.

New Product Development

New product development is increasingly focused on combining high-quality optics with compact digital imaging and simplified clinical workflows. Manufacturers are working to improve polarization, illumination uniformity, sensor resolution, image capture speed, and ergonomic handling. Product development programs are targeting approximately 12% improvements in optical consistency while reducing unnecessary physical bulk by approximately 10%. These improvements are particularly valuable for clinics where equipment must be moved frequently between consultation rooms or integrated into high-volume examination routines.

Another major development direction is the integration of image storage, wireless connectivity, and longitudinal comparison capabilities. Digital Dermatoscope systems are increasingly being designed to capture standardized images and transfer them efficiently into digital clinical workflows. Developers are also investigating software-assisted visualization and structured image comparison, while maintaining clinician oversight of diagnostic interpretation. Selected product concepts are targeting approximately 15% reductions in documentation effort and around 10% improvements in image acquisition efficiency. Future product differentiation is therefore expected to depend on the combined performance of optics, hardware, software, connectivity, and user-centered clinical design.

Five Recent Developments

  • January 2025 Digital Imaging Enhancement: Manufacturers increasingly prioritized higher-resolution digital capture and improved illumination control, with selected systems targeting approximately 10% improvements in image acquisition consistency for repeated dermatological examinations.
  • May 2025 Compact Device Engineering: Product development increasingly emphasized smaller and lighter dermatoscope assemblies, with selected designs targeting approximately 10% reductions in physical footprint while retaining stable optical and electrical performance.
  • September 2025 Connected Documentation: Digital platforms increasingly incorporated improved image-transfer and storage workflows, with connected documentation approaches targeting approximately 15% reductions in repetitive manual image-recording activities across clinical examinations.
  • February 2026 Optical Performance Refinement: Development activity increasingly focused on polarization, illumination uniformity, and lens optimization, with selected configurations targeting approximately 12% improvements in visual consistency during professional lesion assessment.
  • June 2026 Longitudinal Monitoring Support: Digital dermatology platforms increasingly emphasized structured comparison of images captured during follow-up visits, with workflow improvements targeting approximately 20% reductions in time required to organize repeat-examination documentation.

Report Coverage

The Epiluminescence Microscopy market coverage evaluates product demand across Traditional Dermatoscope and Digital Dermatoscope configurations and examines adoption across Hospital, Clinic, and Other applications. The analysis considers optical performance, digital imaging, illumination technologies, ergonomic engineering, documentation requirements, equipment replacement, and workflow integration. Market assessment also considers the increasing importance of connected examination systems and longitudinal image comparison, with digital functionality becoming an increasingly important purchasing criterion.

The regional assessment covers North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World, with each region evaluated according to healthcare infrastructure, specialist dermatology activity, technology adoption, product preferences, and replacement opportunities. Competitive analysis considers Dermlite, Heine, Dino-Lite, Canfield Scientific, WelchAllyn, AMD Global, KaWe, FotoFinder, Caliber I.D., Firefly Global, and Metaoptima. The report further evaluates investment priorities, product development, competitive positioning, clinical workflow requirements, and emerging opportunities shaping market development through 2035.

Epiluminescence Microscopy Market Report Coverage

REPORT COVERAGE DETAILS
Market Size Value In USD 485.06 Million in 2026
Market Size Value By USD 1340.69 Million by 2035
Growth Rate CAGR of 12.1% from 2026-2035
Forecast Period 2026 - 2035
Base Year 2025
Historical Data Available Yes
Regional Scope Global
Segments Covered
By Type Traditional Dermatoscope | Digital Dermatoscope
By Application Hospital | Clinic | Other

Frequently Asked Questions

The global Epiluminescence Microscopy market is expected to reach USD 1340.69 Million by 2035.

The Epiluminescence Microscopy market is expected to exhibit a CAGR of 12.1% by 2035.

Dermlite, Heine, Dino-Lite, Canfield Scientific,WelchAllyn,AMD Global, KaWe, FotoFinder, Caliber I.D., Firefly Global, Metaoptima.

In 2026, the Epiluminescence Microscopy market value stood at USD 485.06 Million.

Our
Clients

Google Bosch Pfizer Sony Deloitte Accenture Dupont BASF Ansell Nvidia Airbus Dell Fresenius Siemens abbott yamaha samsung Duracell novonordisk huawei UPS Deloitte Fresenius yamaha samsung uniliver Amgen Kohler Samyang kaman Gallagher hoerbiger Itochu ITIC kINSEY EY Mitsubishi Staller